- Round ID
- FR-00446
- Stage
- Series C
- Round name
- Series C
- Amount
- $75M
Dated funding evidence
Nuclera
Series C · $75M · 2024-10-16
Reported round$75MSeries C
- Disclosure date
- 2024-10-16
- Reported currency
- USD
- Companies House
- 08663936
- Evidence sources
- 2
Company
NucleraCH 086639362024-10-16Series C$75M
Resolved investor records
Elevage Medical TechnologiesLead investorBritish Patient CapitalInvestorCambridge Innovation CapitalInvestorGK GohInvestorM&G CatalystInvestorVerve VenturesInvestor
3 additional source-listed names are retained in the record fields below but not linked without an exact canonical match.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Elevage Medical Technologies
- Other investors
- British Patient Capital, Cambridge Innovation Capital, GK Goh, M&G Catalyst, E Ink Holdings, Michael D. McCreary, Uni Power Group, Verve Ventures
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.